drugset / Trial / NCT00088205
Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
The purposes of this study are to determine the safety of oral enzastaurin and any side effects that might be associated with it and whether enzastaurin can help participants with mantle cell lymphoma.
Timeline
- Start
- 2004-03
- Primary completion
- 2008-05
- Completion
- 2008-05
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | enzastaurin | Small molecule | 500 mg | Oral |